Net Worth Advisory Group Reduces Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Net Worth Advisory Group reduced its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 20.8% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 1,257 shares of the medical equipment provider’s stock after selling 331 shares during the quarter. Net Worth Advisory Group’s holdings in Intuitive Surgical were worth $623,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Brighton Jones LLC boosted its stake in Intuitive Surgical by 24.9% in the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after purchasing an additional 731 shares in the last quarter. Union Bancaire Privee UBP SA purchased a new position in shares of Intuitive Surgical in the fourth quarter worth $6,509,000. Bank of Stockton lifted its stake in shares of Intuitive Surgical by 13.5% during the fourth quarter. Bank of Stockton now owns 1,161 shares of the medical equipment provider’s stock worth $606,000 after buying an additional 138 shares during the period. Savant Capital LLC grew its holdings in shares of Intuitive Surgical by 17.8% during the fourth quarter. Savant Capital LLC now owns 6,803 shares of the medical equipment provider’s stock valued at $3,551,000 after buying an additional 1,030 shares during the last quarter. Finally, Soltis Investment Advisors LLC increased its position in shares of Intuitive Surgical by 12.1% in the 4th quarter. Soltis Investment Advisors LLC now owns 582 shares of the medical equipment provider’s stock valued at $304,000 after acquiring an additional 63 shares during the period. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have commented on ISRG shares. Truist Financial lowered their price target on Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating for the company in a research report on Wednesday, April 23rd. Barclays decreased their target price on Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating for the company in a report on Thursday, April 24th. Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Thursday, June 5th. Citigroup restated a “buy” rating and set a $650.00 price objective (up from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Finally, Royal Bank of Canada cut their price objective on shares of Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 23rd. One research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $588.95.

Insider Activity

In other news, EVP Gary Loeb sold 1,700 shares of the firm’s stock in a transaction that occurred on Friday, April 25th. The stock was sold at an average price of $513.18, for a total value of $872,406.00. Following the transaction, the executive vice president now owns 2,245 shares in the company, valued at $1,152,089.10. This trade represents a 43.09% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Jami K. Nachtsheim sold 2,400 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $520.00, for a total value of $1,248,000.00. Following the completion of the sale, the director now directly owns 6,371 shares in the company, valued at $3,312,920. This represents a 27.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 4,998 shares of company stock worth $2,611,577 over the last 90 days. 0.70% of the stock is currently owned by company insiders.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $522.41 on Thursday. The stock has a market capitalization of $187.24 billion, a PE ratio of 81.50, a price-to-earnings-growth ratio of 5.85 and a beta of 1.67. The business has a 50 day simple moving average of $524.49 and a 200-day simple moving average of $538.83. Intuitive Surgical, Inc. has a 12 month low of $413.82 and a 12 month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.71 by $0.10. The firm had revenue of $2.25 billion for the quarter, compared to analysts’ expectations of $2.19 billion. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. During the same quarter last year, the company earned $1.50 EPS. On average, equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.